Gemina Laboratories Ltd.
GLABF
$0.77
$0.03384.59%
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -15.99% | -10.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.31% | 15.33% | |||
| Operating Income | 10.31% | -15.33% | |||
| Income Before Tax | 9.95% | -15.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.95% | -15.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.95% | -15.55% | |||
| EBIT | 10.31% | -15.33% | |||
| EBITDA | 10.10% | -15.45% | |||
| EPS Basic | 11.46% | -15.66% | |||
| Normalized Basic EPS | 10.17% | -13.46% | |||
| EPS Diluted | 11.46% | -15.66% | |||
| Normalized Diluted EPS | 10.17% | -13.46% | |||
| Average Basic Shares Outstanding | 1.31% | 0.29% | |||
| Average Diluted Shares Outstanding | 1.31% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
